Matthew Belmonte is currently working at Passkey Therapeutics as a Principal Scientist. Prior to this, he held positions at Cyteir Therapeutics, LifeMine Therapeutics, AstraZeneca, Repligen Corporation, and Novartis. Matthew has a strong background in cell biology, target identification, assay development, and preclinical studies, contributing to the development of several novel compounds for various therapeutic areas. He has a Master's degree in Cell and Molecular Biology from Boston University and a Bachelor's degree in Biotechnology from the University of Massachusetts Lowell.
This person is not in any teams